Lin, J.-W.; Lin, Y.-C.; Liu, J.-M.; Liu, S.-H.; Fang, K.-M.; Hsu, R.-J.; Huang, C.-F.; Chang, K.-Y.; Lee, K.-I.; Chang, K.-C.;
et al. Norketamine, the Main Metabolite of Ketamine, Induces Mitochondria-Dependent and ER Stress-Triggered Apoptotic Death in Urothelial Cells via a Ca2+-Regulated ERK1/2-Activating Pathway. Int. J. Mol. Sci. 2022, 23, 4666.
https://doi.org/10.3390/ijms23094666
AMA Style
Lin J-W, Lin Y-C, Liu J-M, Liu S-H, Fang K-M, Hsu R-J, Huang C-F, Chang K-Y, Lee K-I, Chang K-C,
et al. Norketamine, the Main Metabolite of Ketamine, Induces Mitochondria-Dependent and ER Stress-Triggered Apoptotic Death in Urothelial Cells via a Ca2+-Regulated ERK1/2-Activating Pathway. International Journal of Molecular Sciences. 2022; 23(9):4666.
https://doi.org/10.3390/ijms23094666
Chicago/Turabian Style
Lin, Jhe-Wei, Yi-Chun Lin, Jui-Ming Liu, Shing-Hwa Liu, Kai-Min Fang, Ren-Jun Hsu, Chun-Fa Huang, Kai-Yao Chang, Kuan-I Lee, Kai-Chih Chang,
and et al. 2022. "Norketamine, the Main Metabolite of Ketamine, Induces Mitochondria-Dependent and ER Stress-Triggered Apoptotic Death in Urothelial Cells via a Ca2+-Regulated ERK1/2-Activating Pathway" International Journal of Molecular Sciences 23, no. 9: 4666.
https://doi.org/10.3390/ijms23094666
APA Style
Lin, J.-W., Lin, Y.-C., Liu, J.-M., Liu, S.-H., Fang, K.-M., Hsu, R.-J., Huang, C.-F., Chang, K.-Y., Lee, K.-I., Chang, K.-C., Su, C.-C., & Chen, Y.-W.
(2022). Norketamine, the Main Metabolite of Ketamine, Induces Mitochondria-Dependent and ER Stress-Triggered Apoptotic Death in Urothelial Cells via a Ca2+-Regulated ERK1/2-Activating Pathway. International Journal of Molecular Sciences, 23(9), 4666.
https://doi.org/10.3390/ijms23094666
